Concepedia

Valeria Voevoda-Dimenshtein

VV

3

Publications

80

Citations

3

H-Index

2019

Active since

Affiliations

Tel Aviv University(Current)

Sheba Medical Center

Hebrew University of Jerusalem

Valeria Voevoda-Dimenshtein is an author at Tel Aviv University specializing in cell signaling, cell biology, and tumor biology.

Top concepts

Publications per year

2019–2022

3

Publications

3

CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progression

Katia Beider, Valeria Voevoda-Dimenshtein, Ali Zoabi et al. · Journal of Hematology & Oncology · 2022 · 40 citations · Full text

Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies

Katia Beider, Orit Itzhaki, Jacob Schachter et al. · Cells · 2022 · 26 citations · Full text

The mTOR inhibitor everolimus overcomes CXCR4-mediated resistance to histone deacetylase inhibitor panobinostat through inhibition of p21 and mitotic regulators

Katia Beider, Hanna Bitner, Valeria Voevoda-Dimenshtein et al. · Biochemical Pharmacology · 2019 · 14 citations

, , +11

Rows per page

1–3 of 3